## Core Concept
Methotrexate is an antifolate drug used in the treatment of various cancers and autoimmune diseases. It works by inhibiting dihydrofolate reductase (DHFR), an enzyme crucial for DNA synthesis and cell replication. This mechanism is key to understanding its therapeutic and toxic effects.

## Why the Correct Answer is Right
The correct answer, , states that methotrexate is a folate antagonist that inhibits dihydrofolate reductase (DHFR). This is accurate because methotrexate competitively inhibits DHFR, which is necessary for the conversion of dihydrofolic acid to tetrahydrofolic acid. Tetrahydrofolic acid is required for purine and pyrimidine synthesis, and thus methotrexate effectively starves cells of the necessary components for DNA synthesis and cell division. This action is particularly detrimental to rapidly dividing cells, such as cancer cells and certain immune cells.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately describe the mechanism or a well-recognized characteristic of methotrexate.
- **Option B:** This option is incorrect as it also fails to accurately represent a recognized property or mechanism of action of methotrexate.
- **Option C:** Although not provided, any other option would be incorrect based on the same logic that it does not accurately describe methotrexate's mechanism of action or a known characteristic.

## Clinical Pearl / High-Yield Fact
A key clinical pearl regarding methotrexate is that its toxicity can be reversed by administering **folinic acid** (leucovorin), which bypasses the DHFR inhibition. This is particularly important in cases of methotrexate overdose or when attempting to reduce toxicity without compromising its therapeutic effects.

## Correct Answer Line
**Correct Answer: D. Folate antagonist that inhibits dihydrofolate reductase.**